Through our blog, we hope to create a community where we can support and challenge each other through conversations, discussions and storytelling, and work together to move the field of oncology forward.

  • The Role of Comprehensive Genomic Profiling in Colorectal Cancer

    March is Colorectal Cancer (CRC) Awareness Month, and while CRC is an important topic of conversation year-round, this is an especially critical time to reflect on how scientific research and advancements in personalized medicine are transforming the outlook for people living with this disease. CRC is the third most …

    Continue Reading

  • Partnerships Are Paving the Way for Improved Patient Options

    This article was originally published on LinkedIn. Over the past ten years, there has been a fundamental shift in the way cancer is being treated. Access to genomic data has evolved the way the community thinks about researching, detecting, and treating cancer. Due to this shift, the expansion of the genomic …

    Continue Reading

  • A Year of Change and an Exciting Chapter Ahead

    This article was originally published on LinkedIn. December is always a busy time. Suddenly everyone seems to be filled with a sense of urgency and purpose as the holidays approach and the year draws to a close. There’s almost a static charge to the air; a feeling of anticipation around what the new year may bring …

    Continue Reading

  • ASH 2019: Can Rapid Precision Medicine Help Older Adults With AML?

    When someone is diagnosed with acute myeloid leukemia (AML), doctors typically initiate treatment within 24-48 hours of diagnosis given the aggressive nature of the disease. This urgency to treat precludes the use of ancillary test results, such as genomic profiling, to guide upfront treatment decision making and …

    Continue Reading

  • Breast cancer – a very personal history and an even more personalized future

    This article was originally published on LinkedIn. As I sat down to write this latest post, I was suddenly struck by how little I have written about breast cancer over the course of these articles. This came as quite a surprise given that breast cancer research has played an important, if not always welcome part in …

    Continue Reading

  • CTOS 2019: Navigating the sarcoma maze with CGP

    Every cancer presents its challenges, but sarcomas are particularly troublesome. They are tricky to diagnose and have few treatment options. Sarcomas are a group of rare and diverse cancers. With more than 80 subtypes, this type of cancer can be susceptible to misdiagnosis and there are very limited treatment …

    Continue Reading

  • ESMO 2019: Comprehensive Genomic Profiling Leverages Data Insights to Improve Patient Care

    As scientists worldwide continue to pioneer breakthroughs and change the way we understand and treat advanced cancer, it’s important to stay connected so we can learn from one another. The annual European Society for Medical Oncology (ESMO) Congress is one such opportunity for the cancer community to share the latest …

    Continue Reading

  • A new partnership to accelerate the potential of personalized monitoring in cancer

    This article was originally published on LinkedIn. ESMO is once again around the corner and with it comes the building anticipation for the data and discussions that will continue to shape the future of oncology. This year’s theme, Translating science into better patient care, is particularly pertinent for me …

    Continue Reading

  • More than two decades of work in oncology have shown me that cancer, especially advanced cancer, is often—and understandably—frightening and overwhelming, but developing the right, measured plan is key to helping patients navigate their treatment journeys with more reassurance, confidence, and success. And in my first …

    Continue Reading

  • The breadth of precision medicine at ASCO 2019

    The way ASCO started for me this year set the scene for what was an inspiring and fascinating weekend. Early on Friday morning, before most people’s ASCOs had started, I sat in a meeting room in the conference center watching it slowly fill to the brim with people. I was there to participate in a panel discussion on …

    Continue Reading